
There is currently an urgent global need for point of care diagnostic tests to identify people who are infected with the SARS-CoV-2 virus (Covid-19). Current PCR-based testing requires samples to be shipped to a centralised testing laboratory which means that results typically take 24 hours of more to be confirmed. As the world moves beyond the first pandemic spike and populations emerge from lockdown, there will be an increased need for rapid testing options which can underpin test-trace-isolate strategies.
A University of Warwick team have demonstrated that the SARS-CoV-2 spike protein binds to certain glycan (sugar) molecules, that glycan-functionalised nanoparticles can be used to detect the spike protein and that these nanoparticles can be incorporated into a pregnancy test-style lateral flow device diagnostics.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.